LINC 2023: Late-breaking Science Video Collection

Published: 20 June 2023

Views:
794
Likes:
7

Views:
794
Likes:
7
Share:

Now Playing
Part 1 | Session 5 of 9
TINTIN: Combination DCB and Bare Metal Stents In PAD: 4 Year Outcomes
Koen Deloose

Up Next
7m 13s

Part 1 | Session 6 POPCORN Registry: DCB Treatment for Peripheral Artery Disease
Yoshimitsu Soga
3m 49s

Part 1 | Session 7 MOTIV Bioresorbable Scaffold in BTK Lesions
Michel Bosiers
6m 6s

Part 1 | Session 8 Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK
Marc Sirvent
8m 56s

Part 1 | Session 9 LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions
Sahil Parikh

5m 2s

Part 1 | Session 1 AVPAS: Lutonix AV Post-Approval Study Scott O Trerotola

5m 18s

Part 1 | Session 2 The ELEGANCE Registry: Ranger DCB In Under-Represented Groups Marianne Brodmann

4m 51s

Part 1 | Session 3 RANGER II SFA: 3 Year Patency and 4 Year Clinical Safety Marianne Brodmann

4m 48s

Part 1 | Session 4 IN.PACT AV ACCESS: Outcomes to Date Matteo Tozzi

Average (ratings)

No ratings

Your rating

Overview

Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

Expert Interviews

Short, accessible Expert Interviews with select faculty focusing on the results, applicability, and impact on future research.

9 sessions
AVPAS: Lutonix AV Post-Approval Study	Watch now
The ELEGANCE Registry: Ranger DCB In Under-Represented Groups	Watch now
RANGER II SFA: 3 Year Patency and 4 Year Clinical Safety	Watch now
IN.PACT AV ACCESS: Outcomes to Date	Watch now
TINTIN: Combination DCB and Bare Metal Stents In PAD: 4 Year Outcomes	Watch now
POPCORN Registry: DCB Treatment for Peripheral Artery Disease	Watch now
MOTIV Bioresorbable Scaffold in BTK Lesions	Watch now
Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK	Watch now
LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions	Watch now

About the episode

LINC 23 - We are joined by Dr Koen Deloose (AZSint Blasius Hospital, BE) to discuss the findings of the TINTIN trial, a prospective-investigator initiated, non-randomized multicenter trial investigating the Luminor DCB in combination with the iVolution self-expandable stent in patients with peripheral arterial disease (PAD).

100 patients with PAD were enrolled in the trial and were followed up at 1, 6, 12, 24, 36, 48 and 60 months after their initial procedure. Findings show that at 48 months, there was a 61% survival rate.

Interview Questions:

What was the reasoning behind this trial?
Tell us more about the Luminor DCB and the iVolution Self-expandable stent. Why did you decide to use these in combination?
What was the patient population and study design?
What were the main findings revealed at LINC 23?
What are your take-home messages?
What further study is still needed?

Recorded remotely from Dendermonde, 2023.
Editor: Jordan Rance
Video Specialist: Dan Brent

Faculty Biographies

Koen Deloose

Director of Vascular Surgery

Director of vascular surgery at AZ Sint-Blasius Hospital, Dendermonde, BE.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.